Updates on the Role of Probiotics against Different Health Issues: Focus on Lactobacillus
暂无分享,去创建一个
M. Zakria | M. Ikram | Shakir Ullah | Amjad Khan | Sami Siraj | M. K. Tipu | Myeong-Ok Kim | Arifa Un-Nisa
[1] Laping He,et al. Characterization, High-Density Fermentation, and the Production of a Directed Vat Set Starter of Lactobacilli Used in the Food Industry: A Review , 2022, Foods.
[2] M. Kim,et al. Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants , 2022, Cells.
[3] A. Kusiak,et al. Probiotics: Should All Patients Take Them? , 2021, Microorganisms.
[4] G. L. Garrote,et al. Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains , 2021, Foods.
[5] M. Kim,et al. Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ1–42-Induced Alzheimer’s Disease , 2021, International journal of molecular sciences.
[6] M. Kim,et al. Antioxidative and Anti-inflammatory Effects of Kojic Acid in Aβ-Induced Mouse Model of Alzheimer’s Disease , 2021, Molecular Neurobiology.
[7] Hyoung-Gon Lee,et al. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer’s disease , 2021, Molecular neurodegeneration.
[8] H. Hsieh-Li,et al. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease , 2020, Brain, Behavior, and Immunity.
[9] Y. Probst,et al. Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review. , 2020, Advances in nutrition.
[10] C. Patel,et al. Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.
[11] S. Govoni,et al. Targeting the microbiota in pharmacology of psychiatric disorders. , 2020, Pharmacological research.
[12] H. Szajewska,et al. Use of Probiotics for the Management of Acute Gastroenteritis in Children. An Update. , 2020, Journal of pediatric gastroenterology and nutrition.
[13] J. Sim,et al. Regulatory effects of Lactobacillus plantarum HY7714 on skin health by improving intestinal condition , 2020, PloS one.
[14] F. He,et al. Long-term combined administration of Bifidobacterium bifidum TMC3115 and Lactobacillus plantarum 45 alleviates spatial memory impairment and gut dysbiosis in APP/PS1 mice. , 2020, FEMS microbiology letters.
[15] F. Tabandeh,et al. The effect of lactobacillus cell size on its probiotic characteristics. , 2020, Anaerobe.
[16] M. Salami,et al. Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease , 2019, Behavioural Brain Research.
[17] Pei Jiang,et al. Oral treatment with Lactobacillus reuteri attenuates depressive-like behaviors and serotonin metabolism alterations induced by chronic social defeat stress. , 2019, Journal of psychiatric research.
[18] Z. Pirtošek,et al. Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies , 2019, Front. Neurol..
[19] D. Chung,et al. Combination treatment with lipoteichoic acids isolated from Lactobacillus plantarum and Staphylococcus aureus alleviates atopic dermatitis via upregulation of CD55 and CD59. , 2019, Immunology letters.
[20] You-jin Jang,et al. Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis , 2019, Frontiers in molecular biosciences.
[21] M. Salami,et al. The Effects of Probiotic Lactobacillus and Bifidobacterium Strains on Memory and Learning Behavior, Long-Term Potentiation (LTP), and Some Biochemical Parameters in β-Amyloid-Induced Rat’s Model of Alzheimer’s Disease , 2019, Preventive nutrition and food science.
[22] P. Han,et al. Extracellular Vesicles Derived from Lactobacillus plantarum Increase BDNF Expression in Cultured Hippocampal Neurons and Produce Antidepressant-like Effects in Mice , 2019, Experimental neurobiology.
[23] Joseph D. Gardinier,et al. Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] Jin-zhong Xiao,et al. Heat-killed Lactobacillus helveticus strain MCC1848 confers resilience to anxiety or depression-like symptoms caused by subchronic social defeat stress in mice , 2019, Bioscience, biotechnology, and biochemistry.
[25] M. Liong,et al. Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study. , 2019, Beneficial microbes.
[26] Christopher M. Taylor,et al. Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota , 2019, Front. Immunol..
[27] R. Froissart,et al. Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics , 2019, Scientific Reports.
[28] S. Pongor,et al. Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiome , 2019, Experimental Gerontology.
[29] Enass Y. Osman,et al. Comparative therapeutic efficacy study of Lactobacilli probiotics and citalopram in treatment of acute stress-induced depression in lab murine models , 2018, Human Microbiome Journal.
[30] M. Azad,et al. Immunomodulatory Effects of Probiotics on Cytokine Profiles , 2018, BioMed research international.
[31] D. Pietrella,et al. Anti-inflammatory effect of multistrain probiotic formulation (L. rhamnosus, B. lactis, and B. longum). , 2018, Nutrition.
[32] Alexandra Papadopoulou,et al. Efficacy of an Oral Rehydration Solution Enriched with Lactobacillus reuteri DSM 17938 and Zinc in the Management of Acute Diarrhoea in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial , 2018, Nutrients.
[33] M. Tremblay,et al. Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions? , 2018, Front. Cell. Neurosci..
[34] Hongwei Zhou,et al. Gut microbiota in patients with Parkinson's disease in southern China. , 2018, Parkinsonism & related disorders.
[35] P. Aich,et al. Probiotics L. acidophilus and B. clausii Modulate Gut Microbiota in Th1- and Th2-Biased Mice to Ameliorate Salmonella Typhimurium-Induced Diarrhea , 2018, Probiotics and Antimicrobial Proteins.
[36] H. Weiner,et al. A probiotic modulates the microbiome and immunity in multiple sclerosis , 2018, Annals of neurology.
[37] Y. Huh,et al. Probiotic Lactobacillus sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model , 2018, Front. Microbiol..
[38] R. McIntyre,et al. Targeting cytokines in reduction of depressive symptoms: A comprehensive review , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[39] T. Chun,et al. Oral administration of Lactobacillus plantarum CJLP133 and CJLP243 alleviates birch pollen‐induced allergic rhinitis in mice , 2018, Journal of applied microbiology.
[40] H. Lassmann. Multiple Sclerosis Pathology. , 2018, Cold Spring Harbor perspectives in medicine.
[41] M. Safa,et al. Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1-42) injected rats. , 2018, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[42] C. Blondeau,et al. Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice. , 2018, Beneficial microbes.
[43] M. Murakami,et al. Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice , 2018, Front. Microbiol..
[44] Young-Seo Park,et al. Potential probiotic Lactobacillus plantarum Ln4 from kimchi: Evaluation of β-galactosidase and antioxidant activities , 2017 .
[45] M. Mahmoudi,et al. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[46] Junling Shi,et al. Identification, characterization, and probiotic potential of Lactobacillus rhamnosus isolated from human milk , 2017 .
[47] M. Salami,et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. , 2017, Clinical nutrition.
[48] E. Mitchell,et al. Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial , 2017, EBioMedicine.
[49] K. Śliżewska,et al. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health , 2017, Nutrients.
[50] J. Gordon,et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells , 2017, Science.
[51] Mallikarjuna Nimgampalle,et al. Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's Disease induced Albino Rats. , 2017, Journal of clinical and diagnostic research : JCDR.
[52] G. Deuschl,et al. Gut microbiota in Parkinson disease in a northern German cohort , 2017, Brain Research.
[53] K. Nightingale,et al. Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health , 2017, Journal of applied microbiology.
[54] Francisco Javier Ruiz-Ojeda,et al. Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases , 2017, Nutrients.
[55] M. Mimura,et al. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data , 2017, Psychopharmacology.
[56] Luis Pedro Coelho,et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.
[57] V. Azevedo,et al. Evaluation of Potential Probiotics Isolated from Human Milk and Colostrum , 2017, Probiotics and Antimicrobial Proteins.
[58] Ramón Cacabelos,et al. Parkinson’s Disease: From Pathogenesis to Pharmacogenomics , 2017, International journal of molecular sciences.
[59] Shengyu Li,et al. Reduction of Aflatoxin B1 Toxicity by Lactobacillus plantarum C88: A Potential Probiotic Strain Isolated from Chinese Traditional Fermented Food “Tofu” , 2017, PloS one.
[60] M. Salami,et al. Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial , 2016, Front. Aging Neurosci..
[61] K. Fassbender,et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.
[62] B. Johnston,et al. Probiotics and the Prevention of Antibiotic-Associated Diarrhea in Infants and Children. , 2016, JAMA.
[63] K. Yokoyama,et al. Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis. , 2016, Journal of dairy science.
[64] N. Jetté,et al. The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis , 2016, Neuroepidemiology.
[65] H. Y. Lee,et al. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits , 2016, Molecular Psychiatry.
[66] X. Wu,et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress , 2015, Neuroscience.
[67] R. Baldessarini,et al. Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials , 2015, The international journal of neuropsychopharmacology.
[68] Yasunori Nakamura,et al. Lactobacillus helveticus–fermented milk improves learning and memory in mice , 2015, Nutritional neuroscience.
[69] E. Dinleyici,et al. The history of probiotics: the untold story. , 2015, Beneficial microbes.
[70] K. Barrett,et al. Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice. , 2014, American journal of physiology. Gastrointestinal and liver physiology.
[71] Glenn R. Gibson,et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .
[72] Dong-Hyun Kim,et al. Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a D-galactose-induced accelerated aging mouse model. , 2014, Anaerobe.
[73] K. Tillisch. The effects of gut microbiota on CNS function in humans , 2014, Gut microbes.
[74] Zhiqiang Liu,et al. Treatment of Allergic Rhinitis with Probiotics: An Alternative Approach , 2013, North American journal of medical sciences.
[75] V. Young,et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. , 2013, Gastroenterology.
[76] Ksenija Uroić,et al. Proteolytic activity of probiotic strain Lactobacillus helveticus M92. , 2013, Anaerobe.
[77] Maria Kechagia,et al. Health Benefits of Probiotics: A Review , 2013, ISRN nutrition.
[78] M. Han,et al. Lactobacillus pentosus var. plantarum C29 protects scopolamine‐induced memory deficit in mice , 2012, Journal of applied microbiology.
[79] V. Théodorou,et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats , 2012, Psychoneuroendocrinology.
[80] Á. Gil,et al. Probiotic Mechanisms of Action , 2012, Annals of Nutrition and Metabolism.
[81] Katherine H. Huang,et al. A framework for human microbiome research , 2012, Nature.
[82] Toshihide Kobayashi,et al. Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models , 2012, Immunopharmacology and immunotoxicology.
[83] J. Wells. Immunomodulatory mechanisms of lactobacilli , 2011, Microbial cell factories.
[84] M. Messaoudi,et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers , 2011, Gut microbes.
[85] Kuo-Chen Chou,et al. A Multi-Label Classifier for Predicting the Subcellular Localization of Gram-Negative Bacterial Proteins with Both Single and Multiple Sites , 2011, PloS one.
[86] F. Spertini,et al. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[87] G. Riezzo,et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants , 2011, European journal of clinical investigation.
[88] R. Mayeux,et al. Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.
[89] R. Kumar,et al. Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague–Dawley rats , 2010, British Journal of Nutrition.
[90] L. Chuang,et al. Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora , 2010, Clinical Oral Investigations.
[91] S. Sørensen,et al. Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.
[92] J. Rhee,et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders , 2010, Proceedings of the National Academy of Sciences.
[93] P. Scully,et al. Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses , 2009, Biological Psychiatry.
[94] S. Salminen,et al. Handbook of Probiotics and Prebiotics , 2008 .
[95] S. D. De Keersmaecker,et al. Supporting Probiotic Action Genes and Molecules of Lactobacilli Genes and Molecules of Lactobacilli Supporting Probiotic Action Mechanisms of Health-promoting Effects of Lactobacilli: Probiotic Factors..747 , 2022 .
[96] S. Im,et al. Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. , 2008, Molecular immunology.
[97] Ji Yeun Kim,et al. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. , 2008, Journal of microbiology and biotechnology.
[98] R. Rao,et al. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[99] V. Korolik,et al. Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.
[100] K. Fellermann,et al. Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2 , 2008, Clinical and experimental immunology.
[101] W. Walker. Mechanisms of action of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[102] G. Vinderola,et al. Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria , 2007, Clinical and Vaccine Immunology.
[103] T. Tompkins,et al. Surface‐layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells , 2007, Cellular microbiology.
[104] G. Perdigón,et al. The Probiotic Bacterium Lactobacillus casei Induces Activation of the Gut Mucosal Immune System through Innate Immunity , 2006, Clinical and Vaccine Immunology.
[105] R. Bibiloni,et al. VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis , 2005, The American Journal of Gastroenterology.
[106] S. Nuding,et al. NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium , 2004, Infection and Immunity.
[107] R. Bourdet-Sicard,et al. Lactobacillus casei reduces CD8+ T cell‐mediated skin inflammation , 2004, European journal of immunology.
[108] A. Saggioro. Probiotics in The Treatment of Irritable Bowel Syndrome , 2004, Journal of clinical gastroenterology.
[109] N. Barden. CRSN Symposium : Focus on Depression , Part I Symposium du CRSN : le point sur la dépression , première partie Implication of the hypothalamic – pituitary – adrenal axis in the physiopathology of depression , 2004 .
[110] G. Reid. Safety of lactobacillus strains as probiotic agents. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[111] J. Gruenwald,et al. Effect of a probiotic multivitamin compound on stress and exhaustion , 2002, Advances in therapy.
[112] Michelle M. Garrison,et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. , 2002, Pediatrics.
[113] N. Sipsas,et al. Lactobacillus rhamnosus endocarditis complicating colonoscopy. , 2001, The Journal of infection.
[114] S. Salminen,et al. Probiotics in the management of atopic eczema , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[115] K. Kailasapathy,et al. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. , 2000, Immunology and cell biology.
[116] F. Rouillon. Anxiety with depression: a treatment need , 1999, European Neuropsychopharmacology.
[117] H. Kauma,et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[118] H. Szajewska,et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. , 1998, Journal of pediatric gastroenterology and nutrition.
[119] H. Mykkänen,et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. , 1997, The Pediatric infectious disease journal.
[120] C. Singer,et al. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. , 1997, Journal of travel medicine.
[121] D. Harty,et al. Enzyme production by lactobacilli and the potential link with infective endocarditis. , 1995, The Journal of applied bacteriology.
[122] D. Lilly,et al. Probiotics: Growth-Promoting Factors Produced by Microorganisms , 1965, Science.
[123] T. Fog,et al. [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.
[124] Dong Hyun Kim,et al. Lactobacillus mucosae and Bifidobacterium longum synergistically alleviate immobilization stress-induced anxiety/depression in mice by suppressing gut dysbiosis. , 2019, Journal of microbiology and biotechnology.
[125] J. Segura-Aguilar,et al. Protective Effects of Crude Plant Extracts against Aminochrome-induced toxicity in Human Astrocytoma Cells: Implications for Parkinson's Disease. , 2019, Clinical pharmacology and translational medicine.
[126] Ren-Long Jan,et al. Lactobacillus gasseri attenuates allergic airway inflammation through PPARγ activation in dendritic cells , 2017, Journal of Molecular Medicine.
[127] W. Pace,et al. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. , 2012, Clinical therapeutics.
[128] R.. Probiotics in man and animals , 2008 .
[129] M. H. Kontroab,et al. Communicating Current Research and Educational Topics and Trends in Applied Microbiology , 2007 .
[130] G. Reid,et al. Probiotics: 100 years (1907-2007) after Elie Metchnikoff's Observations , 2007 .
[131] G. Reid,et al. Oral Administration of the Probiotic Combination Lactobacillus Rhamnosus GR-1 and L. Fermentum RC-14 for Human Intestinal Applications , 2002 .
[132] M. Kalliomäki,et al. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. , 2002, The Journal of allergy and clinical immunology.
[133] B. Mollet,et al. Biotechnological Research and the Dairy Industry , 2001 .
[134] M. Hollingsworth,et al. Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[135] G. Tannock,et al. Probiotics for farm animals. , 1999 .